Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05138289 · ClinicalTrials.gov registry record
The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
A clinical trial, sponsored by HeartFlow.
- Completed
- Registry status
- 258
- Enrollment target
NCT05138289: Completed study, sponsored by HeartFlow.
NCT05138289 is a clinical trial that has completed, run by HeartFlow. The registered enrollment target is 258 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05138289 has completed, sponsored by HeartFlow.
- COMPLETED
- Registry status
- 258 participants
- Enrollment target
Study Summary
This study will evaluate the level of agreement between noninvasive CCTA (coronary computed tomography angiography)-based quantification and characterization of coronary atherosclerosis and invasive IVUS (intravascular ultrasound).
Primary Outcome
Level of agreement between total plaque volume measured by AI-QCPA (Artificial intelligence quantitative coronary plaque analysis) and IVUS (intravascular ultrasound).
Interventions
- OTHER Total Plaque Volume
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2022-11-08 |
What the finished NCT05138289 record still lists
NCT05138289 is an observational study that tracks outcomes without assigning an intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Total Plaque Volume is the first listed.
NCT05138289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05138289 about?
NCT05138289 is a clinical study titled "The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA". This study will evaluate the level of agreement between noninvasive CCTA (coronary computed tomography angiography)-based quantification and characterization of coronary atherosclerosis and invasive IVUS (intravascular ultrasound).
What is the current status of trial NCT05138289?
This trial is currently completed. The enrollment target is 258 participants. The study started on 2021-10-12. Estimated completion is 2022-11-08.
What interventions are being tested in trial NCT05138289?
The interventions under investigation include: Total Plaque Volume (OTHER).
Who is sponsoring clinical trial NCT05138289?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI